Skip to main
MLSS
MLSS logo

Milestone Scientific (MLSS) Stock Forecast & Price Target

Milestone Scientific (MLSS) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Milestone Scientific Inc. is projected to experience a sales growth rate of 20% as the medical segment begins to contribute modestly in 2025 and accelerates further in 2026. This expected increase in revenue is supported by enhanced coverage of the CompuFlo procedure by more Medicare Administrative Contractors (MACs) and a strategic shift towards direct online sales in the dental sector. Additionally, the company has demonstrated significant improvement in profitability, with gross margins rising to 76.1% in the second quarter of 2024, up from 65% in the same quarter the previous year.

Bears say

Milestone Scientific Inc. faces potential financial challenges due to the need for increased investment in inventory and marketing, which may strain working capital and delay profitability. Additionally, a significant percentage of second dental appointments are canceled due to patient apprehension, contributing to lost revenue for dentists and impacting the company's sales. Lastly, adverse economic conditions or shifts in healthcare reimbursement may result in dentists being hesitant to invest in the company’s technology, further suppressing growth prospects.

Milestone Scientific (MLSS) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Milestone Scientific and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Milestone Scientific (MLSS) Forecast

Analysts have given Milestone Scientific (MLSS) a Buy based on their latest research and market trends.

According to 1 analysts, Milestone Scientific (MLSS) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $1.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $1.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Milestone Scientific (MLSS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.